Delivery Order SPE2DB22D9239-SPE2DB24FDG81
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS and has an ultimate completion date of April 15, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which is valued at up...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 6, 2024. DMS Pharmaceutical Group is a key supplier for the DLA, holding a $499,999,999 Indefinite Delivery Contract to...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand ten vials of XENPOZYME 20 MG. The place of performance will be Park Ridge, Illinois and all work must be completed by December 18, 2023. As a woman-owned small business, DMS Pharmaceutical Group holds an indefinite delivery contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $87,418.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xenpozyme 20 mg vials. The contract was awarded on September 4, 2025, with an ultimate completion date of September 25, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $87,418.08 by the Defense Logistics Agency on July 30, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product XENPOZYME 20MG 1EA GEN. The order is valued at $218,545.20 and is scheduled for completion on October 19, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $72,848.40 and a completion date of February 2, 2024. The order is for the pharmaceutical product XENPOZYME 20 MG VIALS. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceuticals and medical supplies to the federal government, particularly the Department...
- The Defense Logistics Agency awarded a delivery order valued at $70,393.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xenpozyme 20 mg vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 12, 2026, and carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $201,718.80 to DMS Pharmaceutical Group Inc. for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, issued on September 29, 2025, is expected to be completed by October 21, 2025, with fulfillment occurring at the contractor's facility in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on equal footing despite its status as a woman-owned small...
- The U.S. Defense Logistics Agency has awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of XENPOZYME 20 MG VIALS. The total potential value of the contract is $72,848.40 with a completion date of March 11, 2024. This Delivery Order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Vehicle contract, 4600082013, with the Defense Logistics Agency's SPE2DB program. This single-award IDV enables the...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDG81Delivery Order
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XENPOZYME 20 mg vials. The $109,272.60 contract has a completion date of March 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, particularly the Department of Veterans Affairs and Department of Defense. This delivery order contract is part of a larger $4,999,999 indefinite delivery vehicle that DMS Pharmaceutical Group holds with the Defense Logistics Agency to supply a variety of pharmaceutical products to military health facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $109.3k | 2/27/24 |